Rothblatt, United Therapeutics CEO, sells $3.4m in UTHR stock
NeutralFinancial Markets

Martine Rothblatt, the CEO of United Therapeutics, has sold $3.4 million worth of UTHR stock. This move is significant as it reflects Rothblatt's financial strategy and could impact investor perceptions of the company. While stock sales by executives can sometimes raise eyebrows, they are not uncommon and can be part of personal financial planning.
— Curated by the World Pulse Now AI Editorial System